Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Forceval is a comprehensive multivitamin and mineral supplement manufactured by Alliance Pharmaceuticals. It is formulated with a combination of 24 essential micronutrients, including vitamins A (as β-carotene), B-complex (B1, B2, B6, B12), C, D2, and E, alongside a broad spectrum of minerals and trace elements such as calcium, iron, zinc, selenium, and magnesium. Forceval is indicated as a therapeutic nutritional adjunct in clinical conditions where nutrient intake or absorption is compromised. This includes patients with malabsorption syndromes, inflammatory bowel disease (IBD), Crohn's disease, and those recovering from major surgery or prolonged illness. It is also used in the management of patients with malignancy or immune deficiency syndromes like AIDS, and for individuals on restricted or special diets. The product is available in soft gelatin capsule and effervescent soluble tablet formulations and is accessible without a prescription in certain regions, such as the UK.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Forceval.